We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Goat Pathogen Infects Humans

By LabMedica International staff writers
Posted on 15 Apr 2015
Anaplasmosis is often associated with thrombocytopenia, leukopenia, and/or increased liver enzyme levels in patients with a history of tick exposure within the prior three weeks. More...


Anaplasmosis can be severe and even life-threatening if untreated or initiation of antibiotic therapy is delayed in elderly and in immunocompromised patients, however in most patients anaplasmosis is a mild disease and case fatality rates are low.

Scientists at the Beijing Institute of Microbiology and Epidemiology (China) collected blood samples from patients with a history of tick bite in the preceding two months at a local hospital from May 1, to June 10, 2014. To detect the novel Anaplasma species they used nested polymerase chain reaction (PCR). They inoculated positive samples into cell cultures and characterized the isolated pathogen by morphological and phylogenetic analyses. They also tested serum antibodies by indirect immunofluorescence assay.

The team found 28 of 477 (6%) patients assessed were infected with the novel Anaplasma species according to PCR and sequencing. They isolated the pathogen in vitro from three patients. Phylogenetic analyses of several protein-gene combinations including, major surface protein-2 (msp2), and msp4, showed that the pathogen was distinct from all known Anaplasma species. The nucleotide sequences amplified from all positive samples were identical to each other, and to the corresponding sequences detected in goats.

The majority of patients had seroconversion or a four-fold increase in antibody titers. All 28 patients developed non-specific febrile manifestations, including fever in 23 (82%), headache in 14 (50%), malaise in 13 (46%), dizziness in nine (32%), myalgia in four (14%), and chills in four (14%). Additionally, ten (36%) of 28 patients had rash or eschar, eight (29%) had lymphadenopathy, eight (29%) had gastrointestinal symptoms, and three (11%) had stiff neck. Five patients were admitted to hospital because of severe disease. Six (35%) of 17 patients with data available had high hepatic aminotransferase concentrations.

The authors provisionally nominated the pathogen as "Anaplasma capra.” A similar pathogen Anaplasma ovis is found in sheep and goats and very rarely infects humans. The known vector of Anaplasma capra is the hard tick The study was published on March 29, 2015, in the journal Lancet Infectious Diseases.

Related Links:

Beijing Institute of Microbiology and Epidemiology 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.